Keyphrases
Autosomal Dominant Alzheimer's Disease
100%
Imaging Biomarkers
100%
Longitudinal Imaging
100%
Non-carriers
100%
Biomarker Changes
100%
Mutation Carriers
75%
Dementia
75%
Hypometabolism
75%
Pittsburgh Compound B
50%
Pittsburgh Compound B PET
50%
Asymptomatic Carriers
50%
MRI Data
50%
Cortical Thinning
50%
18F-fluorodeoxyglucose PET
50%
Clinical Trials
25%
Pathological Features
25%
Presenilin 2
25%
Amyloid Precursor Protein
25%
Presenilin
25%
Dominantly Inherited Alzheimer Network
25%
Divergence
25%
Neurodegenerative Diseases
25%
Gene mutation
25%
Alzheimer's Disease Model
25%
Between-group
25%
Structural Magnetic Resonance Imaging (sMRI)
25%
Glucose Metabolism
25%
Clinical Setting
25%
Imaging Data
25%
PET-MRI
25%
Region of Interest
25%
Disease Course
25%
Cortical Regions
25%
Metabolic
25%
Symptom Onset
25%
Pathological Changes
25%
Linear Mixed Model
25%
Accruals
25%
Medical Research Council
25%
U.S. National Institutes of Health
25%
Regional Vulnerability
25%
Precuneus
25%
Background Modeling
25%
Biomarker Trajectories
25%
Estimated Rates
25%
Structural Impairment
25%
Temporal Vulnerability
25%
Biomarker Ordering
25%
Biochemistry, Genetics and Molecular Biology
Autosomal Dominant Inheritance
100%
Pittsburgh Compound B
100%
Magnetic Resonance Imaging
100%
Presenilin
100%
Clinical Trial
50%
Amyloid Precursor Protein
50%
Gene Mutation
50%
Glucose Metabolism
50%
Amyloid Protein
50%
Neuroscience
Alzheimer's Disease
100%
Positron Emission Tomography
100%
Longitudinal Study
100%
Magnetic Resonance Imaging
50%
Fluorine-18
50%
Neurodegenerative Disorder
25%
Metabolic Pathway
25%
Amyloid Precursor Protein
25%
Gene Mutation
25%
Presenilin 1
25%
Precuneus
25%
Amyloid Protein
25%
Presenilin 2
25%